Mode
Text Size
Log in / Sign up
Phase 4 N=155 Randomized Double-blind Treatment

CBT-I or Zolpidem/Trazodone for Insomnia

Chronic Insomnia

Enrolled (actual)
155
Serious AEs
1.9%
Results posted
Feb 2025
Primary outcome: Primary: Change in Insomnia Symptom Severity — -8.05; -7.82; -10.19 change score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Zolpidem (Drug); Internet Cognitive Behavioral Therapy for Insomnia (CBT-I) (Behavioral); Trazodone (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
California Pacific Medical Center Research Institute
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Insomnia Symptom Severity
-8.05; -7.82; -10.19
SECONDARY
Number of Participants With Treatment Response of Insomnia Symptoms
22; 21; 31
SECONDARY
Number of Participants With Remission of Insomnia Symptoms
16; 13; 16

Summary

This study is a randomized (1:1:1) comparative effectiveness trial of medication (zolpidem or trazodone), cognitive-behavioral therapy for insomnia (CBT-I), and the combination (medication + CBT-I) for the treatment of chronic insomnia in men and women aged 18-80 living in rural areas with 1 year of follow-up. A total of 155 participants will be enrolled and randomized in the United States. This trial is funded by the Patient-Centered Outcomes Research Institute.

Eligibility Criteria

Inclusion Criteria

  • Age 18-80
  • Insomnia Severity Index score > 10
  • Regular internet and computer access
  • Receives primary care in a Non-metropolitan/Rural residence

Exclusion Criteria

  • Use of hypnotic medication >2 times in the past week
  • Current cognitive or cognitive behavioral treatment for insomnia
  • Psychotic disorder
  • Bipolar disorder
  • Current substance use disorder
  • Severe Chronic obstructive pulmonary disease (COPD) or other severe pulmonary disease (such as asthma or lung fibrosis)
  • Cognitive impairment or dementia
  • History of spontaneous or hypnotic-induced complex sleep behavior
  • Delayed sleep phase disorder (DSPD)
  • Shift work that includes working the night shift (between the hours of 12:00 a.m. - 6:00 a.m.)
  • History of fracture or injurious fall in the past 12 months
  • Currently pregnant, planning to become pregnant, or breastfeeding
  • Other severe or uncontrolled mental or physical disorders that would make participation difficult or unsafe
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04468776). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search